Bionano Genomics, Inc. (BNGO) — Institutional Holders, Q2 2026

35 institutional investment managers reported a BNGO position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $801.6K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

BNGO in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

8

Added to

11

Trimmed

2

Sold out

6

Biggest buyers

  1. CARRET ASSET MANAGEMENTAdded · +55,000 sh+$62.1K
  2. JANE STREET GROUPNew · +35,728 sh+$40.4K
  3. XTX Topco LtdNew · +16,295 sh+$18.4K
  4. VANGUARD CAPITAL MANAGEMENTAdded · +14,279 sh+$16.1K
  5. HRT FINANCIALNew · +11,740 sh+$13.3K

Biggest sellers

  1. GSA CAPITAL PARTNERS LLPTrimmed · -203,079 sh-$229.5K
  2. GEODE CAPITAL MANAGEMENTTrimmed · -77,540 sh-$87.6K
  3. TWO SIGMA SECURITIESSold out · -18,056 sh-$20.4K
  4. Virtu FinancialSold out · -13,751 sh-$15.5K
  5. Vanguard Global AdvisersSold out · -173 sh-$195.00

BNGO 13F holders ranked 1–35 of 35

Institutional investors reporting a position in Bionano Genomics, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
GSA CAPITAL PARTNERS LLP#1 · 150,284 sh$170.0K-57.5%
CARRET ASSET MANAGEMENT#2 · 125,000 sh$141.3K+78.6%
GEODE CAPITAL MANAGEMENT#3 · 89,993 sh$101.7K-46.3%
VANGUARD CAPITAL MANAGEMENT#4 · 82,388 sh$93.1K+21.0%
VANGUARD FIDUCIARY#5 · 51,578 sh$58.3K0.0%
RENAISSANCE TECHNOLOGIES#6 · 51,100 sh$57.7K+4.9%
JANE STREET GROUP#7 · 35,728 sh$40.4KNew
PRUDENTIAL FINANCIAL#8 · 31,600 sh$35.7K+12.9%
NORTHERN#9 · 24,561 sh$27.8K+19.7%
XTX Topco Ltd#10 · 16,295 sh$18.4KNew
Engineers Gate Manager#11 · 11,988 sh$13.5K+1.1%
HRT FINANCIAL#12 · 11,740 sh$13.0KNew
BlackRock#13 · 9,937 sh$11.2K0.0%
OSAIC#14 · 7,809 sh$8.8K+14.8%
Tower Research Capital (TRC)#15 · 5,228 sh$5.9KNew
MORGAN STANLEY#16 · 1,037 sh$1.2K+11.9%
Concord Wealth Partners#17 · 1,000 sh$1.1KNew
GROUP ONE TRADING, L.P.#18 · 957 sh$1.1K0.0%
UBS Group AG#19 · 812 sh$918.00+4975.0%
SBI Securities , Ltd.#20 · 246 sh$278.00+5.1%
WELLS FARGO & COMPANY#21 · 113 sh$128.000.0%
BNP PARIBAS FINANCIAL MARKETS#22 · 13 sh$15.000.0%
JPMORGAN CHASE#23 · 11 sh$13.000.0%
Caitong International Asset Management , Ltd#24 · 5 sh$6.00New
TD Waterhouse Canada#25 · 5 sh$6.000.0%
Activest Wealth Management#26 · 3 sh$3.000.0%
BARCLAYS PLC#27 · 3 sh$3.00New
CITIGROUP#28 · 3 sh$3.00+200.0%
NATIONAL BANK OF CANADA#29 · 2 sh$2.000.0%
Ancora Advisors#30 · 1 sh$1.000.0%
Rockefeller Capital Management L.P.#31 · 1 sh$1.00New
Medallion Wealth Advisors#32 · 1 sh$1.000.0%
Union Bankshares#33 · 1 sh$1.000.0%
ROYAL BANK OF CANADA#34 · 11 sh$0.000.0%
Steward Partners Investment Advisory#35 · 0 sh$0.00New

Funds that sold out of BNGO in Q2 2026 (6)

Held BNGO at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held BNGO in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
TWO SIGMA SECURITIES18,056 sh$21.1K
Virtu Financial13,751 sh$16.0K
Vanguard Global Advisers173 sh$202.00
Allworth Financial6 sh$8.00
FMR6 sh$7.00
Aviso Financial1 sh$1.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.